St. Jude (STJ +0.4%) net profit edges up to $123M from $120M last year.
Unfavorable currency fluctuations hurt sales by $27M. On a constant-currency basis, net sales +6%.
Sales breakdown: cardiac rhythm-management +3%; implantable cardiac defibrillator +5%; pacemakers +1%.
Q1 adjusted EPS of $0.94-0.96 vs consensus of $0.95, and revenue of $1.28-1.36B vs $1.38B.
FY adjusted EPS of $3.94-3.99 vs $3.98, and revenue of $5.6-5.75B vs $5.64B. (PR)